Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Angheben

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 13, 2017
Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: TropNet data from the DengueTools Research InitiativeAndreas Neumayr, Jose Muñoz, Mirjam Schunk, et al.
International Journal of Environmental Research and Public Health|January 20, 2021
The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition: The "ImpACT-COVID-19 for Patients" Multi-Centre Observational StudyGiuseppe Deledda, Niccolò Riccardi, Stefania Gori, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
Intensive Care Medicine Experimental|June 29, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trialEvdoxia Kyriazopoulou, Antigone Kotsaki, Asimina Safarika, et al.
Critical Care (London, England)|March 13, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trialEvdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
Clinical Immunology (Orlando, Fla.)|December 14, 2025
Long-term immune and epigenetic dysregulation following COVID-19Chrysanthi Sidiropoulou, Garyphallia Poulakou, Evdoxia Kyriazopoulou, et al.
Elife|October 5, 2022
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patientsBronner P Gonçalves, Matthew Hall, Waasila Jassat, et al.
Nature Medicine|September 4, 2021
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trialEvdoxia Kyriazopoulou, Garyfallia Poulakou, Haralampos Milionis, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 13, 2017
Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: TropNet data from the DengueTools Research InitiativeAndreas Neumayr, Jose Muñoz, Mirjam Schunk, et al.
International Journal of Environmental Research and Public Health|January 20, 2021
The Impact of the SARS-CoV-2 Outbreak on the Psychological Flexibility and Behaviour of Cancelling Medical Appointments of Italian Patients with Pre-Existing Medical Condition: The "ImpACT-COVID-19 for Patients" Multi-Centre Observational StudyGiuseppe Deledda, Niccolò Riccardi, Stefania Gori, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
Intensive Care Medicine Experimental|June 29, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trialEvdoxia Kyriazopoulou, Antigone Kotsaki, Asimina Safarika, et al.
Critical Care (London, England)|March 13, 2024
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trialEvdoxia Kyriazopoulou, Yehudit Hasin-Brumshtein, Uros Midic, et al.
Eclinicalmedicine|January 2, 2023
Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trialKarolina Akinosoglou, Antigone Kotsaki, Ioanna-Maria Gounaridi, et al.
Clinical Immunology (Orlando, Fla.)|December 14, 2025
Long-term immune and epigenetic dysregulation following COVID-19Chrysanthi Sidiropoulou, Garyphallia Poulakou, Evdoxia Kyriazopoulou, et al.
Elife|October 5, 2022
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patientsBronner P Gonçalves, Matthew Hall, Waasila Jassat, et al.
Nature Medicine|September 4, 2021
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trialEvdoxia Kyriazopoulou, Garyfallia Poulakou, Haralampos Milionis, et al.
Pageof 11